Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Total Liabilities
Meridian Bioscience Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Total Liabilities
$95m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Total Liabilities
$4.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Total Liabilities
$3.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Liabilities
$2.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
29%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Liabilities
$885.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
6%
|
See Also
What is Meridian Bioscience Inc's Total Liabilities?
Total Liabilities
95m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Total Liabilities amounts to 95m USD.
What is Meridian Bioscience Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
3%
Over the last year, the Total Liabilities growth was -22%. The average annual Total Liabilities growth rates for Meridian Bioscience Inc have been -11% over the past three years , 3% over the past five years .